...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith AGM Agenda

Every year Don has addressed the issue of Zenith liquidity usually because he is forced to by a shareholder's question. Last year he implied there was little value in the stock if it went public and he implied that during this next year (2018 to 2019) things would happen to put value in the stock.

BoM failed. ZCC seems to have a focus of raising private money to fund research.

Any thoughts or guesses on an IPO for Zenith this year?

I'm going to request that this issue be formally addressed at the AGM this year.

GLTA

Toinv

Share
New Message
Please login to post a reply